Eqis Capital Management, Inc. Lantheus Holdings, Inc. Transaction History

Eqis Capital Management, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$55.54 - $72.65 $173,118 - $226,450	3,117 New	3,117 $205,000
Q3 2021 Nov 12, 2021	SELL	$24.23 - $28.59 $230,281 - $271,719	-9,504 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$19.51 - $27.64 $185,423 - $262,690	9,504 New	9,504 $263,000
Q3 2019 Nov 05, 2019	SELL	$21.01 - $28.94 $269,684 - $371,473	-12,836 Closed	0 $0
Q2 2019 Jul 18, 2019	BUY	$23.33 - $28.3 $299,463 - $363,258	12,836 New	12,836 $363,000
Q1 2019 Apr 18, 2019	SELL	$14.93 - $25.1 $309,334 - $520,046	-20,719 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$12.68 - $19.01 $1.09 Million - $1.63 Million	-85,930 Reduced 80.57%	20,719 $324,000
Q3 2018 Oct 17, 2018	SELL	$13.1 - $16.35 $85,438 - $106,634	-6,522 Reduced 5.76%	106,649 $1.66 Million
Q2 2018 Jul 27, 2018	BUY	$13.65 - $18.7 $213,991 - $293,159	15,677 Added 16.08%	113,171 $1.65 Million
Q1 2018 Apr 06, 2018	BUY	$14.85 - $24.3 $482,966 - $790,308	32,523 Added 50.06%	97,494 $1.55 Million
Q4 2017 Jan 25, 2018	BUY	$17.4 - $23.4 $246,035 - $330,876	14,140 Added 27.82%	64,971 $1.33 Million
Q3 2017 Oct 03, 2017	BUY	$15.5 - $19.15 $787,880 - $973,413	50,831	50,831 $905,000

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.1B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.